scispace - formally typeset
V

Vineet Kumar

Researcher at Science Applications International Corporation

Publications -  66
Citations -  1860

Vineet Kumar is an academic researcher from Science Applications International Corporation. The author has contributed to research in topics: Ionic liquid & Catalysis. The author has an hindex of 24, co-authored 66 publications receiving 1667 citations. Previous affiliations of Vineet Kumar include Johns Hopkins University & University of Delhi.

Papers
More filters
Journal ArticleDOI

Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activities

TL;DR: Aristolactams, having a phenanthrene chromophore are a small group of compounds mainly found in the Aristolochiaceae together with the aristolochic acids and 4,5-dioxoaporphines, which are reviewed and classified on the basis of their oxygenation pattern.
Journal ArticleDOI

Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells.

TL;DR: The studies showed 2-trifluoromethyl-2'-methoxychalone (2b) to be a potent activator of Nrf2, both in vitro and in mice, and showed that the activation of NRF2 by this compound is independent of reactive oxygen species or redox changes.
Journal ArticleDOI

Study on the potential anti-cancer activity of phosphonium and ammonium-based ionic liquids

TL;DR: In this paper, the anti-cancer activity and cytotoxicity of ammonium and phosphonium-based ionic liquids (ILs) have been determined for the first time via NCI's in vitro 60 human tumor cell lines.
Journal ArticleDOI

A profile of the in vitro anti-tumor activity of imidazolium-based ionic liquids.

TL;DR: The ionic liquids with alkyl substitution of C-12 chain length were found to be effective against all 60 tumor cell lines and show very low cytotoxicity in most of the cases.
Journal ArticleDOI

NRF2-mediated Notch pathway activation enhances hematopoietic reconstitution following myelosuppressive radiation

TL;DR: It is determined that activation of nuclear factor erythroid-2-related factor 2 (NRF2) signaling enhances hematopoietic stem progenitor cell (HSPC) function and mitigates IR-induced myelosuppression and mortality in mice.